Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Atea Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 115 | 3 | 111 | −1 |
| Shares | 53.2M | 106.4K | 57.0M | +3.94M (+7.4%) |
| Value | $154.2M | $308.7K | $203.5M | +$49.6M (+32.2%) |
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 179,815 | $641.9K | 0.08% |
| Aldebaran Capital, LLC | 90,529 | $323.2K | 0.29% |
| Nomura Asset Management International Inc. | 70,000 | $250.0K | 0.00% |
| Point72 Asset Management, L.P. | 63,905 | $228.1K | 0.00% |
| Deutsche Bank AG | 52,714 | $188.2K | 0.00% |
| Nano Cap New Millennium Growth Fund L P | 50,000 | $178.5K | 0.15% |
| Schonfeld Strategic Advisors LLC | 45,921 | $163.9K | 0.00% |
| Squarepoint Ops LLC | 19,311 | $68.9K | 0.00% |
| RFG Advisory, LLC | 14,875 | $53.1K | 0.00% |
| Smartleaf Asset Management LLC | 3,300 | $11.7K | 0.00% |
| Rockefeller Capital Management L.P. | 940 | $3.36K | 0.00% |
Sold out (12)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Newtyn Management, LLC | 492,284 | $1.43M |
| Macquarie Group Ltd | 70,000 | $203.0K |
| Brevan Howard Capital Management LP | 29,450 | $85.4K |
| Algert Global LLC | 28,199 | $81.8K |
| Bluefin Capital Management, LLC | 24,216 | $70.2K |
| Ameriprise Financial Inc | 22,618 | $65.6K |
| Public Employees Retirement System of Ohio | 16,100 | $46.7K |
| Shay Capital LLC | 14,466 | $42.0K |
| Prudential Financial Inc | 10,135 | $29.4K |
| Allworth Financial LP | 63 | $183 |
| Covestor Ltd | 93 | $0 |
| Cloud Capital Management, LLC | 59 | $0 |
Not filed for Q4 2025 yet (3)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 87,774 | $254.5K |
| Wolverine Trading, LLC | 14,982 | $43.7K |
| Point72 Asia (Singapore) Pte. Ltd. | 3,601 | $10.4K |